Industry News
Trial Compares Ways To Elicit Patient Values About Prostate-Specific Antigen Screening
Feb 11, 2013
Michael Patrick Pignone, M.D., M.P.H., of the University of North Carolina, Chapel Hill, and colleagues conducted a randomized clinical in October 2011 in which men underwent a values clarification task and then chose the most important attribute for prostate-specific antigen (PSA) screening... Read More
"Achilles' Heal" Found For Lymphoid Leukemia
Feb 11, 2013
International Study Suggests Improved Treatment Alternative for Lymphoid Leukemia Discovering what they call the "Achilles' heel" for lymphoid leukemia, an international research team has tested a possible alternative treatment that eradicated the disease in mouse models. Reporting their results Feb... Read More
Mouse Model Of Clear Cell Sarcoma Improves Understanding Of Rare, Deadly Cancer
Feb 11, 2013
May Speed Development of Drugs to Target Gene Mutation Geneticists led by University of Utah Nobel Prize Laureate Mario R. Capecchi have engineered mice that develop clear cell sarcoma (CCS), a significant step in better understanding how this rare and deadly soft tissue cancer arises... Read More
"Achilles' Heal" Found For Lymphoid Leukemia
Feb 11, 2013
International Study Suggests Improved Treatment Alternative for Lymphoid Leukemia Discovering what they call the "Achilles' heel" for lymphoid leukemia, an international research team has tested a possible alternative treatment that eradicated the disease in mouse models. Reporting their results Feb... Read More
VAXIMM Reports Positive Topline Data From First Oral Cancer Vaccine Trial
Feb 11, 2013
Study meets endpoints and demonstrates safety and tolerability of VXM01 VAXIMM AG, a Swiss-German biotech company focusing on oral cancer vaccines, announced today topline data from the first clinical trial of its investigational oral cancer vaccine VXM01... Read More
New Freezing Procedure Increases Availability Of Cord Blood Stem Cell Transplants For Patients
Feb 11, 2013
A large enough number of stem cells are needed to ensure the success of a cord blood transplant. However, the quantity of stem cells isolated from umbilical cord blood is not always sufficient to meet that requirement. Researchers from the Etablissement Français du Sang, Aquitaine-Limousin (France) have established a method to multiply cord blood stem cells to required quantity levels... Read More
New Freezing Procedure Increases Availability Of Cord Blood Stem Cell Transplants For Patients
Feb 11, 2013
A large enough number of stem cells are needed to ensure the success of a cord blood transplant. However, the quantity of stem cells isolated from umbilical cord blood is not always sufficient to meet that requirement. Researchers from the Etablissement Francais du Sang, Aquitaine-Limousin (France) have established a method to multiply cord blood stem cells to required quantity levels... Read More
Treating Cancers, Neurological Disorders, And Infectious Diseases Using Unique Peptide
Feb 11, 2013
UT Southwestern Medical Center scientists have synthesized a peptide that shows potential for pharmaceutical development into agents for treating infections, neurodegenerative disorders, and cancer through an ability to induce a cell-recycling process called autophagy... Read More
Anticancer Drug Not Found To Accelerate Tumor Growth After Treatment Ends
Feb 11, 2013
Studies in animals have raised concerns that tumors may grow faster after the anticancer drug sunitinib is discontinued. But oncologists and physicists who collaborated to analyze data from the largest study of patients with kidney cancer convincingly demonstrate that such tumor acceleration does not occur in humans... Read More
Using MicroRNA To Identify Triple-Negative Breast Cancer Subtypes
Feb 11, 2013
A new, large-scale study of triple-negative breast cancer shows that small molecules called microRNA can be used to define four subtypes of this aggressive malignancy. The findings, by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J... Read More
Previous Page Next Page